All In Biotech

Drug Trial Radar · NCT04461535

Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)

Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism The ADOPA Randomized Clinical Trial

Last checked: Nov 19, 2026Latest source record: Dec 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 228 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

228

Actual

Start

Jul 8, 2020

Primary completion

Feb 20, 2023

Study completion Feb 20, 2023

Sponsor

Lead sponsor
Chongqing Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 8, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the effect of different procedures of AVS(with or without ACTH stimulation) on the long-term outcomes of patients with PA

Conditions

  • Primary Aldosteronism

Interventions

  • Adrenocorticotropic hormoneDrug

    Patients divided into Intervention group need to undergo stimulation with a continuous cosyntropin infusion (50 μg/h started 30 minutes before sampling during AVS). Right and left adrenal venous blood and corresponding peripheral venous blood should be sampled sequentially.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Compare the proportion of surgically treated patients with complete biochemical remission in the overall cohort between two groupsTime frame: At 12 months of follow-up.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affilated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.